Jobs

Full-time in Singapore! Director Drug-Resistant Infections Clinical Research Network

COVID-related heads-up: FDA has announced that VRBPAC (Vaccines and Related Biological Products Advisory Committee) will meet on 10 Dec 2020 to discuss the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19. Go here for details.   Dear All, There’s a serious job opportunity in Singapore: The National University of Singapore seeks a full-time Director for

Read More »

AMR Action Fund ($1b for P2-3) seeks Scientific Advisory Board

Dear All, I’ve previously written about the AMR Action Fund (9 Jul 2020 newsletter), a $1b fund created by 20+ global pharma with the intertwined goals of (i) bringing 2-4 new antibacterial antibiotics through Phase 2-3 and approval by 2030 and (ii) creating market conditions that enable sustainable investment in antibiotics. While we know that the

Read More »

Global AMR Hub (Berlin) seeks Scientific Program Officer

Dear All, The G20’s Global AMR R&D Hub (https://globalamrhub.org/, see below my signature for a brief history of the Hub) has a job opening from 1 Feb 2021 for a Scientific Program Officer. Here’s a brief description of the role:  Contributes expert knowledge on AMR R&D to the further development of the Dynamic Dashboard and to

Read More »

Beyond Pull: Maximizing availability + (appropriate!) use / Help needed!

Dear All, Today we have two interwoven topics to consider: An analysis of research priorities (not all technical!) and a triad of related initiatives, each of which comes with an opportunity for you to starting working on some of those priorities! First up, we have an excellent new paper summarizing the perspective of 32 experts

Read More »

Wellcome Trust RFP: Landscape Report on Early antibiotic development

Dear All, The Wellcome Trust Drug-Resistant Infections team wants to understand what researchers in academia and SMEs need to enable them to be better able to make progress with their early antibiotic discovery projects. Although some programs are now in place (e.g., the accelerator support provided by CARB-X), what are the remaining barriers?  To help

Read More »

Consultants for WHO’s SECURE, Wellcome-ICARS-Danish Gov’t AMR event

Dear All, See below my signature: A 6-month consultancy with WHO to support the the SECURE initiative, a program to assist countries in accessing and sustainably managing new and existing antibiotics needed to cope with antimicrobial resistance (AMR). There’s not much online (yet) about SECURE: the best description I can find is in the Terms of Reference

Read More »

WHO consultancy: Rollout of Policy Guidance on Integrated Stewardship Activities

Dear All, Just below my signature you will find the full details on a recently posted WHO consultancy opportunity. It’s an intriguing 6-month project during which you would be responsible for the rollout and implementation of a new WHO Policy Guidance on the Implementation of Integrated Antimicrobial Stewardship Activities. This guidance will be rolled out in

Read More »
Scroll to Top